FROM HIV / AIDS

• Study Of NEF Protein Released Due To HIV Infection Could Lead To New Therapeutic Developments
• Targeting HIV Viral Reservoirs – The Next Frontier in the AIDS Battle.
• Study shows that Testosterone may aid HIV male patients with better BMD (bone mineral density).
• HIV latency in the various body tissues varies.
• Future Trends In PrEP, moving beyond Truvada.
• New single-tablet regimens show long-term effectiveness in HIV management according to studies.

LATEST ON PR RELEASES

• Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients
• Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection
• AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
• Phase III data showed that Venclexta Venclyxto plus Gazyva Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities
• Phase III HARMONIZE Global trial of Lokelma confirms efficacy in maintaining normal potassium levels in Asian patients with hyperkalaemia
• Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib In RMS.